Imophoron (private company)
See something wrong or missing? Let us know
Offices:Bristol
Industry:Health servicesManufacturing
Business model:B2B
Imophoron is the developer of a novel next-generation rapid-response vaccine platform, ADDomer, used to combat present and future infectious diseases, and potential outbreaks, known as ‘Disease X’.
Investors:
we tracked 3 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.43M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Imophoron
Name | Criteria | |
---|---|---|
![]() |
Oivi
58%
|
|
![]() |
Aidee Health
58%
|
|
![]() |
Jutro Medical
58%
|
|
![]() |
Nanolyze
58%
|
|
![]() |
Octarine Bio
58%
|
|
![]() |
Pilloxa
58%
|
|
![]() |
Dele Health
58%
|
|
![]() |
Kaspard
55%
|
|
![]() |
AorticLab
55%
|
|
![]() |
Flow Robotics
55%
|
|